ABSTRACT
Abstract Human Bocavirus (HBoV) has been identified from feces and respiratory samples from cases of both acute gastroenteritis and respiratory illness as well as in asymptomatic individuals. The aim of this study was to detect and characterize HBoV from fecal samples collected from hospitalized children aged less than five years old with no symptoms of respiratory tract infection (RTI) or acute gastroenteritis (AGE). The study involved 119 children and one fecal sample was collected from each participant between 2014 and 2015. HBoV was detected using Nested-PCR, and the viral type identified by genomic sequencing. HBoV-4 was identified from one sample obtained from a hospitalized child with soft tissue tumor of the submandibular region. This is the first report of HBoV-4 identification in Brazil, but we consider that this type may be circulating in the country similar to the other types and new investigations are necessary.
Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Respiratory Tract Infections/virology , Parvoviridae Infections/virology , Human bocavirus/isolation & purification , Gastroenteritis/virology , Respiratory Tract Infections/complications , Respiratory Tract Infections/epidemiology , Soft Tissue Neoplasms/complications , Brazil/epidemiology , Mandibular Neoplasms/complications , Acute Disease , Parvoviridae Infections/complications , Parvoviridae Infections/epidemiology , Human bocavirus/classification , Gastroenteritis/complications , Gastroenteritis/epidemiologyABSTRACT
The purpose of this study was to perform a comparative analysis of Rotavirus A (RVA) G and P genotypes circulating in the Brazilian Mid-West in the period 1986-2015. Seven studies conducted from 1986 to 2009 were included, as well as fecal samples obtained in the period 2014-2015. RVA was screened by ELISA and/or PAGE; genotyping by conventional RT-PCR and/or genomic sequencing. A temporal variation in the predominance of G genotypes mainly G1 and G2 with G9 and G12 emergence was observed. Even with vaccination, RVA continues to circulate in the population, requiring continuous virus monitoring